Cargando…

Implementing Patient-Derived Xenografts to Assess the Effectiveness of Cyclin-Dependent Kinase Inhibitors in Glioblastoma

Glioblastoma (GBM) is the most common primary brain tumor with no available cure. As previously described, seliciclib, a first-generation cyclin-dependent kinase (CDK) inhibitor, down-regulates the anti-apoptotic protein, Mcl-1, in GBM, thereby sensitizing GBM cells to the apoptosis-inducing effects...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noonan, Janis J., Jarzabek, Monika, Lincoln, Frank A., Cavanagh, Brenton L., Pariag, Arhona R., Juric, Viktorija, Young, Leonie S., Ligon, Keith L., Jahns, Hanne, Zheleva, Daniella, Prehn, Jochen H. M., Rehm, Markus, Byrne, Annette T., Murphy, Brona M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966586/ https://www.ncbi.nlm.nih.gov/pubmed/31842413 http://dx.doi.org/10.3390/cancers11122005

Ejemplares similares

Cyclin-dependent kinase inhibitors in brain cancer: current state and future directions
por: Juric, Viktorija, et al.
Publicado: (2020)

Sensitization of glioblastoma cells to TRAIL-induced apoptosis by IAP- and Bcl-2 antagonism
por: Lincoln, Frank A., et al.
Publicado: (2018)

Transcriptional CDK Inhibitors CYC065 and THZ1 Induce Apoptosis in Glioma Stem Cells Derived from Recurrent GBM
por: Juric, Viktorija, et al.
Publicado: (2021)

Transcriptional CDK inhibitors, CYC065 and THZ1 promote Bim-dependent apoptosis in primary and recurrent GBM through cell cycle arrest and Mcl-1 downregulation
por: Juric, Viktorija, et al.
Publicado: (2021)

Predicting the cell death responsiveness and sensitization of glioma cells to TRAIL and temozolomide
por: Weyhenmeyer, Birgit C., et al.
Publicado: (2016)

Marizomib sensitizes primary glioma cells to apoptosis induced by a latest-generation TRAIL receptor agonist
por: Boccellato, Chiara, et al.
Publicado: (2021)

Cyclin-dependent kinase inhibitor fadraciclib (CYC065) depletes anti-apoptotic protein and synergizes with venetoclax in primary chronic lymphocytic leukemia cells
por: Chen, Rong, et al.
Publicado: (2022)

Inducing cell death in Glioblastoma
por: Tappuni, Shahed, et al.
Publicado: (2015)

Phenotypic selection through cell death: stochastic modelling of O-6-methylguanine-DNA methyltransferase dynamics
por: Lasri, Ayoub, et al.
Publicado: (2020)

Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft Models
por: O’Farrell, Alice C., et al.
Publicado: (2020)

Interrogation of gossypol therapy in glioblastoma implementing cell line and patient-derived tumour models
por: Jarzabek, M A, et al.
Publicado: (2014)

Relevant uses of surface proteins – display on self‐organized biological structures
por: Jahns, Anika C., et al.
Publicado: (2012)

Antitumor effects of flavopiridol, a cyclin-dependent kinase inhibitor, on human cholangiocarcinoma in vitro and in an in vivo xenograft model
por: Saisomboon, Saowaluk, et al.
Publicado: (2019)

Cyclin-dependent kinase-associated protein phosphatase is overexpressed in alcohol-related hepatocellular carcinoma and influences xenograft tumor growth
por: LIN, WEY-RAN, et al.
Publicado: (2012)

TRAIL signaling promotes entosis in colorectal cancer
por: Bozkurt, Emir, et al.
Publicado: (2021)

Bovine intracranial neoplasia: A retrospective case series
por: Jahns, Hanne, et al.
Publicado: (2022)

Effects of Cyclooxygenase Inhibitors in Combination with Taxol on Expression of Cyclin D1 and Ki-67 in a Xenograft Model of Ovarian Carcinoma
por: Li, Wei, et al.
Publicado: (2012)

Sticky siRNAs targeting survivin and cyclin B1 exert an antitumoral effect on melanoma subcutaneous xenografts and lung metastases
por: Kedinger, Valerie, et al.
Publicado: (2013)

Mitotic entry: Non-genetic heterogeneity exposes the requirement for Plk1
por: Aspinall, Claire F., et al.
Publicado: (2015)

Integrating Colon Cancer Microarray Data: Associating Locus-Specific Methylation Groups to Gene Expression-Based Classifications
por: Barat, Ana, et al.
Publicado: (2015)

Influence of micropatterned substrates on keratocyte phenotype
por: Bhattacharjee, Promita, et al.
Publicado: (2020)

Real-time single cell analysis of Smac/DIABLO release during apoptosis
por: Rehm, Markus, et al.
Publicado: (2003)

Cyclin C: The Story of a Non-Cycling Cyclin
por: Ježek, Jan, et al.
Publicado: (2019)

Durability of cell line xenograft resection models to interrogate tumor micro-environment targeting agents
por: Miller, Ian S., et al.
Publicado: (2019)

Phosphorylation of cyclin O, a novel cyclin family protein containing a cyclin-like domain, is involved in the activation of cyclin-dependent kinase 2
por: KIM, DO HYUNG, et al.
Publicado: (2014)

Multiple myeloma in an Amur tiger (Panthera tigris altaica)
por: Lee, Alison M., et al.
Publicado: (2017)

Limited redundancy in genes regulated by Cyclin T2 and Cyclin T1
por: Ramakrishnan, Rajesh, et al.
Publicado: (2011)

Cyclins in aspergilli: Phylogenetic and functional analyses of group I cyclins
por: Paolillo, V., et al.
Publicado: (2018)

The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer
por: Javed, Aadil, et al.
Publicado: (2023)

Functional Differentiation of Cyclins and Cyclin-Dependent Kinases in Giardia lamblia
por: Kim, Juri, et al.
Publicado: (2023)

Strengthening or Restricting? Explaining the Covid-19 Pandemic’s Configurational Effects on Companies’ Sustainability Strategies and Practices
por: Hamann, Ralph, et al.
Publicado: (2022)

Aurora kinase inhibitors: Progress towards the clinic
por: Kollareddy, Madhu, et al.
Publicado: (2012)

Interrogation of novel CDK2/9 inhibitor fadraciclib (CYC065) as a potential therapeutic approach for AML
por: Chantkran, Wittawat, et al.
Publicado: (2021)

Correction to: Interrogation of novel CDK2/9 inhibitor fadraciclib (CYC065) as a potential therapeutic approach for AML
por: Chantkran, Wittawat, et al.
Publicado: (2021)

Occipital condylar dysplasia in a Jacob lamb (Ovis aries)
por: Lee, Alison M., et al.
Publicado: (2017)

Cyclin K and cyclin D1b are oncogenic in myeloma cells
por: Marsaud, Véronique, et al.
Publicado: (2010)

Combining systems biology models of apoptosis provides superior predictions of the responsiveness of melanoma cells to cell death inducing drugs
por: Curtayne, Paul, et al.
Publicado: (2015)

The Prognostic Value and Overexpression of Cyclin A Is Correlated with Gene Amplification of both Cyclin A and Cyclin E in Breast Cancer Patient
por: Husdal, A., et al.
Publicado: (2006)

Translational control of cyclins
por: Tarn, Woan-Yuh, et al.
Publicado: (2011)

Cyclin-dependent kinases
por: Malumbres, Marcos
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_khuntioisus0phacnhbb31upon